Evidence map›Paper›PMID 38619450›Full record

ArticleThe Journal of cell biology2024

OMA1 clears traffic jam in TOM tunnel in mammals.

Shiori Sekine, Yusuke Sekine

Open access · bronzeAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shiori SekineAging Institute, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0001-9962-833X
Yusuke SekineAging Institute, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-0345-1416
University of Pittsburgh · US

Funding

Deciphering a Novel Mechanism for Iron-sensing at Mitochondria and Its Role in ErythropoiesisR01DK134341 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Xiaojun Tan · 2023 to 2026
$2.0M
NIDDK NIH HHS R01 DK134341NIDDK NIH HHS R01DK134341NIH HHS
6 · The paper itself

Abstract

Using an engineered mitochondrial clogger, Krakowczyk et al. (https://doi.org/10.1083/jcb.202306051) identified the OMA1 protease as a critical component that eliminates import failure at the TOM translocase in mammalian cells, providing a novel quality control mechanism that is distinct from those described in yeast.

Indexed as

MammalsMetalloproteasesMitochondrial Precursor Protein Import Complex ProteinsMitochondrial ProteinsAnimalsMitochondriaPeptide HydrolasesSaccharomyces cerevisiaeMetalloproteasesMitochondrial Precursor Protein Import Complex ProteinsMitochondrial ProteinsPeptide Hydrolases

Identifiers

PMID38619450
PMCPMC11016469
OpenAlexW4394819851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.